AI assistant
Cibus, Inc. — Director's Dealing 2018
Nov 13, 2018
34396_dirs_2018-11-13_15b80cf5-1062-482e-9bac-02515b299a91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Calyxt, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2018-11-08
Reporting Person: Voytas Daniel F (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-08 | Common Stock | M | 4083 | $3.7143 | Acquired | 97065 | Direct |
| 2018-11-08 | Common Stock | S | 4083 | $13.00 | Disposed | 92982 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-08 | Stock Option (Right to Buy) | $3.7143 | M | 4083 | Disposed | 2024-12-03 | Common Stock (4083) | Direct |
Footnotes
F1: Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
F3: The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter).